I also cant really find anything about the intracanical pressure for stroke unless its a foreign country looking into it. I just putting more emphasis on the fact that IIH is an encumbered market, we have no known competitors, we have the leading specialists in our team, like its a free run to glory I like to say and once there no one can take our market share. Its a big pharma buyout no doubt if successful.
$1 billion for IXC if successful as a buyout target is chum change for them. Im sure thats where Jason will come into affect. Anyway lets get there first
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.763M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5 | 9.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.7¢ | 9000 | 1 |
View Market Depth
| Last trade - 16.21pm 14/07/2025 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable